The
Centers for Medicare & Medicaid Services (CMS) announced recently that it
will increase public awareness of financial relationships between drug and
device manufacturers and certain health care providers. This rule, referred to
as the “National Physician Payment Transparency Program: Open Payments,” is one
of many steps in the Affordable Care Act (ACA) designed to create greater
transparency in the health care market.
Under
this new rule, doctors are required to report to CMS when they have a financial
relationship with the companies that manufacture or supply the medicines or
medical devices. Disclosure of these relationships allows patients to have more
informed discussions with their doctors.
Manufacturers
are also required to disclose to CMS physician ownership or investment
interests. This increased transparency is intended to help reduce the
potential for conflicts of interest that physicians or teaching hospitals could
face as a result of their relationships with manufacturers. CMS will release all
data on a public website by September 30, 2014.
We here at The
Fairfax Elder Law Firm of Evan H. Farr
agree that there should be transparency in healthcare, similar to the
transparency of information that is readily available for nursing home care.
Nursing homes are currently rated annually by Medicare, and the quality of care
ratings for more than 17,000 nursing homes is available publically on the web
on Medicare.gov’s Nursing Home Compare website.
Do you
or a loved one need nursing home care in the near future or are you looking to
plan ahead? Call
703-691-1888 to make an appointment for a no-cost consultation. We can meet
with you, access your situation and determine strategies for your long-term
care plan.
No comments:
Post a Comment